Global Canna Labs successfully exports Medical Cannabis from Jamaica to Canada for scientific purposes as its intended use
December 09 2019 - 8:00AM
Elixxer Ltd. (TSX-V: ELXR and OTC-QB: ELXIF)
(“
ELIXXER”) is pleased to announce that Global
Canna Labs has successfully exported 10 kilograms of medical
cannabis from Jamaica into Canada.
Global Canna is one of the foremost medical
cannabis companies in Jamaica. The company operates under a tier 3
operator’s license on its 270,000 square foot facility in the heart
of Montego Bay. The tier 3 license is one of the largest issued
Licensees by the CLA for the cultivation and production of medical
cannabis.
Orville Powell, Chief Operating Officer of
Global Canna remarked, “The commercial export of cannabis flower
from Jamaica to Canada was a very rigorous and challenging process
but in the end we got it done and our team has a tremendous feeling
of satisfaction. The process took effort and coordination
from a number of individuals and parties. Our team at Global Canna
is extremely grateful for the outstanding professionalism shown by
the CLA, the Ministry of Agriculture, Customs and the folks at
the airport.”
Blessed with an ideal microclimate for
economical, high-quality cannabis cultivation, Jamaica has a
storied, world-famous association with the herb through reggae
music and the Rastafarian faith. Global Canna plans to continue
this cherished history by building Jamaican heritage cannabis
brands that will become instant classics, globally.
“Global Canna worked for a significant amount of
time behind the scenes to achieve our export goal. This benchmark
cannabis export scientific purposes as the intended purpose
is very exciting for our company and Jamaica as a whole,”
notes Paul Glavine, President of Global Canna. “The Company looks
forward to additional shipments in Q4, 2019, to more international
markets. The strains were a local 1:1 Jamaican indengious strain
called jack hammer along with wedding cake produced by world
renowned Seed Junky Genetics.”
The CLA is presently working to finalize the
export regulations for the industry which are expected before the
end of this year.
Elixxer’s interest in Global Canna currently
consists of (i) a significant investment of $2.5 million by way of
a secured debenture, convertible into a 30% equity interest in
Global Canna and (ii) a 5% royalty on Global Canna’s net sales.
About Elixxer Ltd.
(www.Elixxer.com)
Elixxer Ltd. is a Canadian incorporated public
company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US
OTC-QB exchange (OTCQB: ELXIF). It currently has investments in
legal cannabis related businesses in Australia, Jamaica,
Switzerland, Italy, and Canada.
Credit: PuffPuffPost
https://www.puffpuffpost.com/global-canna-completes-first-commercial-quantity-export-to-canada/
For further information please
contact:
President, John McMullen, +1-416-803-0698,
john@elixxer.com
Caution Regarding Press
Releases
Neither the TSX Venture Exchange nor its
Regulation Service Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Notice Regarding Forward Looking
Statements
This press release may contain forward-looking
statements with respect to Elixxer and its operations, strategy,
investments, financial performance and condition. These statements
can generally be identified by use of forward-looking words such as
“may”, “will”, “expect”, “estimate”, “anticipate”, “intends”,
“believe” or “continue” or the negative thereof or similar
variations. The actual results and performance of Elixxer could
differ materially from those expressed or implied by such
statements. Such statements are qualified in their entirety by the
inherent risks and uncertainties surrounding future expectations.
Some important factors that could cause actual results to differ
materially from expectations include, among other things, general
economic and market factors, competition, government regulation and
the factors described under “Risk Factors and Risk Management” in
Elixxer’s most recent Management’s Discussion and Analysis filed on
SEDAR (www.sedar.com). The cautionary statements qualify all
forward-looking statements attributable to Elixxer and persons
acting on its behalf. Unless otherwise stated, all forward-looking
statements speak only as of the date of this press release, and
Elixxer has no obligation to update such statements, except to the
extent required by applicable securities laws.
Elixxer (TSXV:ELXR)
Historical Stock Chart
From Jul 2024 to Aug 2024
Elixxer (TSXV:ELXR)
Historical Stock Chart
From Aug 2023 to Aug 2024